Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $532.14 | 30 | 85.8% |
| Education | $88.00 | 1 | 14.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $90.51 | 6 | $0 (2019) |
| Astellas Pharma US Inc | $88.00 | 1 | $0 (2018) |
| Genentech USA, Inc. | $78.09 | 4 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $62.73 | 5 | $0 (2018) |
| Horizon Pharma plc | $61.15 | 1 | $0 (2017) |
| Lupin Inc. | $57.23 | 3 | $0 (2018) |
| PFIZER INC. | $53.83 | 1 | $0 (2023) |
| Shire North American Group Inc | $32.44 | 2 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $26.35 | 2 | $0 (2017) |
| Lupin Pharmaceuticals, Inc | $23.31 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $53.83 | 1 | PFIZER INC. ($53.83) |
| 2020 | $14.15 | 1 | Genentech USA, Inc. ($14.15) |
| 2019 | $98.32 | 5 | Genentech USA, Inc. ($63.94) |
| 2018 | $241.05 | 11 | Astellas Pharma US Inc ($88.00) |
| 2017 | $212.79 | 13 | Horizon Pharma plc ($61.15) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/22/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $53.83 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/02/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Virology & Specialty Care | ||||||
| 03/25/2019 | Boston Scientific Corporation | GENERAL BPH (Device) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: BPH | ||||||
| 02/25/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Virology & Specialty Care | ||||||
| 02/21/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Virology & Specialty Care | ||||||
| 01/18/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Virology & Specialty Care | ||||||
| 01/04/2019 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2018 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2018 | Lupin Inc. | SOLOSEC (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: OBSTETRICSGYNECOLOGY | ||||||
| 09/08/2018 | Mission Pharmacal Company | Uribel (Drug) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: Analgesic, antispasmodic & antiseptic (urinary) | ||||||
| 08/31/2018 | Lupin Inc. | SOLOSEC (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: OBSTETRICSGYNECOLOGY | ||||||
| 08/10/2018 | BOSTON SCIENTIFIC CORPORATION | GENERAL BPH (Device) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: BPH | ||||||
| 06/13/2018 | Lupin Inc. | SUPRAX (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: INFECTIONS AND INFECTIOUS DISEASES | ||||||
| 05/16/2018 | BOSTON SCIENTIFIC CORPORATION | AMS (Device) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: ERECTILE DYSFUNCTION | ||||||
| 05/04/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Respiratory | ||||||
| 04/26/2018 | Astellas Pharma US Inc | — | Education | In-kind items and services | $88.00 | General |
| 02/28/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Respiratory | ||||||
| 01/26/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Respiratory | ||||||
| 12/06/2017 | Horizon Pharma plc | NO_PRODUCT (Drug) | Food and Beverage | In-kind items and services | $61.15 | General |
| Category: NONE | ||||||
| 11/28/2017 | Lupin Pharmaceuticals, Inc | Suprax (Drug) | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: Antibiotic | ||||||
| 11/21/2017 | BOSTON SCIENTIFIC CORPORATION | GREENLIGHT (Device) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: PROSTATE HEALTH | ||||||
| 10/25/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Respiratory | ||||||
| 08/22/2017 | BOSTON SCIENTIFIC CORPORATION | LITHOVUE (Device) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: SCOPE | ||||||
| 08/18/2017 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: Gastroenterology | ||||||
| 07/31/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $10.64 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,203 | 2,581 | $183,532 | $53,087 |
| 2022 | 18 | 1,374 | 3,079 | $210,772 | $62,754 |
| 2021 | 19 | 1,393 | 2,892 | $235,614 | $69,324 |
| 2020 | 20 | 1,391 | 3,319 | $233,371 | $61,744 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 228 | 244 | $62,240 | $22,138 | 35.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 105 | 105 | $40,822 | $11,389 | 27.9% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 133 | 135 | $33,750 | $5,434 | 16.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 120 | 244 | $10,097 | $3,925 | 38.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 59 | $10,178 | $3,150 | 31.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 33 | 33 | $8,375 | $2,418 | 28.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 136 | 212 | $10,235 | $1,961 | 19.2% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 39 | 40 | $2,849 | $857.65 | 30.1% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 48 | 48 | $1,984 | $761.40 | 38.4% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 11 | 11 | $916.30 | $303.89 | 33.2% |
| 80047 | Blood test, basic group of blood chemicals (calcium, ionized) | Office | 2023 | 14 | 14 | $480.62 | $188.44 | 39.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 62 | 64 | $512.00 | $140.80 | 27.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 17 | 17 | $127.50 | $124.95 | 98.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 15 | 15 | $296.00 | $114.15 | 38.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 130 | 1,123 | $336.90 | $94.75 | 28.1% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 32 | 126 | $189.00 | $51.04 | 27.0% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 24 | 91 | $143.78 | $34.18 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 127 | 135 | $34,436 | $14,753 | 42.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 184 | 203 | $35,018 | $12,339 | 35.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 194 | 202 | $50,500 | $8,155 | 16.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 56 | 56 | $21,772 | $8,064 | 37.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 79 | 79 | $20,050 | $5,986 | 29.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 118 | 244 | $10,097 | $3,936 | 39.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 18 | $6,193 | $2,870 | 46.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 151 | 249 | $12,022 | $2,366 | 19.7% |
About Dr. David Wright, M.D
Dr. David Wright, M.D is a Emergency Medicine healthcare provider based in Mount Pleasant, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346200581.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Wright, M.D has received a total of $620.14 in payments from pharmaceutical and medical device companies, with $53.83 received in 2023. These payments were reported across 31 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($532.14).
As a Medicare-enrolled provider, Wright has provided services to 5,361 Medicare beneficiaries, totaling 11,871 services with total Medicare billing of $246,909. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Mount Pleasant, SC
- Active Since 03/23/2006
- Last Updated 01/07/2015
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346200581
Products in Payments
- Xofluza (Drug) $78.09
- SYMBICORT (Drug) $62.73
- NO_PRODUCT (Drug) $61.15
- PAXLOVID (Drug) $53.83
- SOLOSEC (Drug) $37.51
- VYVANSE (Drug) $32.44
- LITHOVUE (Device) $29.27
- Suprax (Drug) $23.31
- SUPRAX (Drug) $19.72
- AMS (Device) $18.64
- GENERAL BPH (Device) $15.29
- GREENLIGHT (Device) $14.64
- BUPAP (Drug) $14.20
- GENERAL BPH (Device) $12.67
- XIFAXAN (Drug) $12.15
- Uribel (Drug) $11.99
- AMRIX (Drug) $11.67
- PROAIR (Drug) $11.60
- Trulance (Drug) $11.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Mount Pleasant
Dr. James Samuel, M.d, M.D
Emergency Medicine — Payments: $235,554
Dr. Christopher Michaelis, D.o, D.O
Emergency Medicine — Payments: $164,039
Dr. Scott Smith, M.d, M.D
Emergency Medicine — Payments: $68,502
Dr. Michael Bauerschmidt, Md, MD
Emergency Medicine — Payments: $574.41
Dr. Joseph Humphrey, M.d, M.D
Emergency Medicine — Payments: $562.38
Thomas Hilliard, M.d, M.D
Emergency Medicine — Payments: $161.57